Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH – Get Free Report) shares rose 7.2% during trading on Wednesday . The company traded as high as $1.22 and last traded at $1.19. 13,906 shares changed hands during mid-day trading, a decline of 92% from the average daily volume of 184,236 shares. The stock had previously closed at $1.11.
Shuttle Pharmaceuticals Stock Down 1.7 %
The firm has a 50 day moving average price of $1.60. The stock has a market cap of $2.65 million, a P/E ratio of -0.35 and a beta of -0.94.
Shuttle Pharmaceuticals (NASDAQ:SHPH – Get Free Report) last announced its quarterly earnings results on Tuesday, September 3rd. The company reported ($0.96) earnings per share for the quarter.
About Shuttle Pharmaceuticals
Shuttle Pharmaceuticals Holdings, Inc, a clinical stage pharmaceutical company, develops novel therapies to cure cancers. It develops Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and sarcomas SP-1-161, an HDAC inhibitor that initiates the mutated in ataxia-telangiectasia response pathway for radiation sensitizing cancer cells and protecting normal cells; SP-2-225, a pre-clinical class IIb that effects on the regulation of the immune system; and SP-1-303, a pre-clinical selective Class I HDAC for the treatment of ER positive cancers .
Read More
- Five stocks we like better than Shuttle Pharmaceuticals
- Why Invest in 5G? How to Invest in 5G Stocks
- Survey Reveals: America’s Most Coveted Businesses in 2024
- How to Invest in Blue Chip Stocks
- Top 3 Stocks to Play Oil’s Potential Comeback Rally
- Bank Stocks – Best Bank Stocks to Invest In
- Analysts See Growth in CrowdStrike Stock Despite July Setback
Receive News & Ratings for Shuttle Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shuttle Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
